XT
AKBA icon

XTX Topco’s Akebia Therapeutics AKBA Stock Holding History

XTX Topco’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-244,453
Closed -$340K – 4113
2026
Q1 		$340K Sell
244,453
-228,032
-48% -$313K 0.01% 2377
2025
Q4 		$761K Buy
472,485
+434,284
+1,137% +$909K 0.02% 1241
2025
Q3 		$104K Sell
38,201
-112,700
-75% -$375K 0.01% 2015
2025
Q2 		$549K Buy
150,901
+104,890
+228% +$288K 0.02% 1023
2025
Q1 		$88.3K Buy
+46,011
New +$93.9K ﹤0.01% 1895
2024
Q4 		– Sell
-44,267
Closed -$58.4K – 2239
2024
Q3 		$58.4K Buy
+44,267
New +$59.1K ﹤0.01% 1674
2024
Q1 		– Sell
-99,645
Closed -$124K – 1790
2023
Q4 		$124K Sell
99,645
-38,861
-28% -$39.6K 0.03% 1086
2023
Q3 		$158K Sell
138,506
-200,861
-59% -$258K 0.03% 1092
2023
Q2 		$311K Buy
+339,367
New +$328K 0.06% 692
2022
Q2 		– Sell
-102,392
Closed -$74K – 823
2022
Q1 		$74K Buy
102,392
+75,635
+283% +$162K 0.03% 552
2021
Q4 		$60K Buy
+26,757
New +$73K 0.03% 544
2021
Q3 		– Sell
-20,589
Closed -$78K – 664
2021
Q2 		$78K Buy
+20,589
New +$69.3K 0.03% 687

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

XTX Topco's AKBA Position: Q2 2026 in Review

XTX Topco sold out of Akebia Therapeutics (AKBA) in Q2 2026, closing a stake of 244,453 shares — an estimated $340K sold.

XTX Topco first reported a position in AKBA in Q2 2021 and held it in 12 quarters. The position peaked at $761K in Q4 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • XTX Topco reported no remaining Akebia Therapeutics position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 244,453 Akebia Therapeutics shares in Q2 2026, an estimated $340K.
  • XTX Topco first reported a position in Akebia Therapeutics in Q2 2021 and held it in 12 quarters.
  • XTX Topco's Akebia Therapeutics position peaked at $761K in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.